Literature DB >> 25399942

Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances.

Daniela Ghetie1, Navid Mehraban1, Cailin H Sibley2.   

Abstract

Cryoglobulins are immunoglobulins that precipitate at temperatures less than 37°C. They occur secondary to infectious, autoimmune, and malignant processes. In the Brouet classification, type I cryoglobulinemia is caused by hyperviscosity, whereas type II and III manifestations are caused by vasculitis in target organs (primarily skin, peripheral nerves, and kidney). New classification criteria were recently proposed that may help with study and treatment of cryoglobulinemic vasculitis (CryoVas). Hepatitis C virus is the most common cause of CryoVas and treatment with antivirals can be curative in mild cases, whereas rituximab is highly effective in treating active vasculitis in more severe cases.

Entities:  

Keywords:  Cryoglobulinemia; Cryoglobulinemic; Diagnosis; HCV; Rituximab; Treatment; Vasculitis

Mesh:

Substances:

Year:  2015        PMID: 25399942     DOI: 10.1016/j.rdc.2014.09.008

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  5 in total

Review 1.  Gastrointestinal aspects of vasculitides.

Authors:  Medha Soowamber; Adam V Weizman; Christian Pagnoux
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-23       Impact factor: 46.802

Review 2.  Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Authors:  Shveta S Motwani; Leal Herlitz; Divya Monga; Kenar D Jhaveri; Albert Q Lam
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

3.  Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosa-associated lymphoid tissue lymphoma treated with rituximab.

Authors:  Austin Y Ha; Nicole Noronha; Patrick Gleason; Jonathan N Winkler; James N Butera; Kammi J Henriksen; Susie L Hu
Journal:  Clin Nephrol Case Stud       Date:  2016-01-19

Review 4.  Pigmented purpura and cutaneous vascular occlusion syndromes.

Authors:  Ana Cecilia Lamadrid-Zertuche; Verónica Garza-Rodríguez; Jorge de Jesús Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

5.  Cryoglobulinemic vasculitis and glomerulonephritis: concerns in clinical practice.

Authors:  Yi-Pu Chen; Hong Cheng; Hong-Liang Rui; Hong-Rui Dong
Journal:  Chin Med J (Engl)       Date:  2019-07-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.